Copyright
©The Author(s) 2016.
World J Gastroenterol. Oct 21, 2016; 22(39): 8720-8734
Published online Oct 21, 2016. doi: 10.3748/wjg.v22.i39.8720
Published online Oct 21, 2016. doi: 10.3748/wjg.v22.i39.8720
Ref. | Years | Study population | OBI |
Fukuda et al[52] | 1999 | 65 patients with HCV-related liver disease | 34/65 (52.3%) |
Kao et al[53] | 2002 | 210 patients with HCV-related liver disease | 31/210 (14.8%) |
Besisik et al[54] | 2003 | 33 HCV positive patients on hemodialysis | 12/33 (36.4%) |
Georgiadou et al[55] | 2004 | 187 patients with HCV-related liver disease | 49/187 |
Khattab et al[56] | 2005 | 53 patients with chronic HCV infection | 4/53 (7.5%) |
Goral et al[57] | 2006 | 50 HCV positive patients on hemodialysis | 0/50 |
Branco et al[43] | 2007 | 46 patients with HCV-related liver disease | 9/46 (19.5%) |
Toyoda et al[58] | 2007 | 95 HCV positive patients with HCC | 2/95 (2.1%) |
Shetty et al[59] | 2008 | 44 HCV positive patients with liver cirrhosis | 22/44 (50%) |
Tamori et al[60] | 2009 | 50 HCV positive patients with HCC | 21/50 (42%) |
Chen et al[61] | 2010 | 126 patients with chronic HCV infection | 6/126 (5%) |
Jang et al[62] | 2011 | 32 patients with chronic HCV infection | 9/32 (28.1%) |
Joukar et al[63] | 2012 | 59 HCV positive patients on hemodialysis | 0/59 |
Vakili Ghartavol et al[64] | 2013 | 50 patients with chronic HCV infection | 18/50(36%) |
Kishk et al[65] | 2014 | 162 patients with chronic HCV infection | 3/162 (1.85%) |
Mandour et al[66] | 2015 | 210 patients with chronic HCV infection | 53/210 (25.2%) |
Ref. | Country | Prevalence % | Year |
Vargas et al[73] | Chile | 0/192 (0) | 2016 |
Alvarez-Muñoz et al[74] | Mexico | 24/49 (49.0) | 2014 |
Chadwick et al[75] | England | 15/335 (4.5) | 2014 |
Coffin et al[76] | Canada | 19/45 (42.0) | 2014 |
Dapena et al[77] | Spain | 6/254 (2.4) | 2013 |
Khamduang et al[78] | Thailand | 47/200 (23.5) | 2013 |
Bell et al[79] | Africa | 45/298 (15.1) | 2012 |
Panigrahi et al[80] | India | 12/112 (10.7) | 2012 |
Bagaglio et al[81] | Italy | 9/29 (31.0) | 2011 |
Gupta et al[82] | India | 24/53 (45.3) | 2010 |
Hakeem et al[83] | Scotland | 2/70 (2.8) | 2010 |
Morsica et al[84] | Italy | 27/175 (15) | 2009 |
Azadmanesh et al[85] | Iran | 3/22 (13.6) | 2008 |
Tsui et al[86] | United States | 8/400 (2.0) | 2007 |
Ref. | Country | No. of samples | No. of OBI cases | No. of cases positive for anti-HBc | Year |
Borzooy et al[188] | Iran | 120 | 4 (3.3) | 0 (0) | 2015 |
Chiarakul et al[189] | Thailand | 36 | 4 (11) | 4 (100) | 2011 |
Slusarczyk et al[185] | Poland | 961 | 6 (4) | 4 (100%) | 2012 |
Shim et al[190] | Korea | 334 | 0 | 0 | 2011 |
Sukriti et al[191] | India | 120 | 6 (5) | 6 (100) | 2008 |
Yen et al[192] | Taiwan | 250 | 16 (6.4) | 13 (81) | 2005 |
- Citation: Makvandi M. Update on occult hepatitis B virus infection. World J Gastroenterol 2016; 22(39): 8720-8734
- URL: https://www.wjgnet.com/1007-9327/full/v22/i39/8720.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i39.8720